Unit of Pharmacology, Department of Experimental Medicine, Second University of Naples, Naples, Italy.
Br J Pharmacol. 2011 Aug;163(8):1740-54. doi: 10.1111/j.1476-5381.2011.01339.x.
BACKGROUND AND PURPOSE Brain natriuretic peptide (BNP) plays an important role in several biological functions, including bronchial relaxation. Here, we have investigated the role of BNP and its cognate receptors in human bronchial tone. EXPERIMENTAL APPROACH Effects of BNP on responses to carbachol and histamine were evaluated in non-sensitized, passively sensitized, epithelium-intact or denuded isolated bronchi and in the presence of methoctramine, N(ω) -nitro-L-arginine methyl ester (L-NAME) and aminoguanidine. Natriuretic peptide receptors (NPRs) were investigated by immunohistochemistry, RT-PCR and real-time PCR. Release of NO and acetylcholine from bronchial tissues and cultured BEAS-2B bronchial epithelial cells was also investigated. KEY RESULTS BNP reduced contractions mediated by carbachol and histamine, with decreased E(max) (carbachol: 22.7 ± 4.7%; histamine: 59.3 ± 1.8%) and increased EC(50) (carbachol: control 3.33 ± 0.88 µM, BNP 100 ± 52.9 µM; histamine: control 16.7 ± 1.7 µM, BNP 90 ± 30.6 µM); BNP was ineffective in epithelium-denuded bronchi. Among NPRs, only atrial NPR (NPR1) transcripts were detected in bronchial tissue. Bronchial NPR1 immunoreactivity was detected in epithelium and inflammatory cells but faint or absent in airway smooth muscle cells. NPR1 transcripts in bronchi increased after incubation with BNP, but not after sensitization. Methoctramine and quinine abolished BNP-induced relaxant activity. The latter was associated with increased bronchial mRNA for NO synthase and NO release, inhibited by L-NAME and aminoguanidine. In vitro, BNP increased acetylcholine release from bronchial epithelial cells, whereas NO release was unchanged. CONCLUSIONS AND IMPLICATIONS Epithelial cells mediate the BNP-induced relaxant activity in human isolated bronchi.
脑钠肽(BNP)在多种生物学功能中发挥重要作用,包括支气管舒张。在这里,我们研究了 BNP 及其同源受体在人支气管张力中的作用。
评估了 BNP 对非致敏、被动致敏、上皮完整或去上皮的离体支气管对卡巴胆碱和组织胺反应的影响,并在甲氧基胺、N(ω)-硝基-L-精氨酸甲酯(L-NAME)和氨基胍存在的情况下进行了评估。通过免疫组织化学、RT-PCR 和实时 PCR 研究了利钠肽受体(NPRs)。还研究了支气管组织和培养的 BEAS-2B 支气管上皮细胞中 NO 和乙酰胆碱的释放。
BNP 降低了由卡巴胆碱和组织胺介导的收缩,减少了 E(max)(卡巴胆碱:22.7 ± 4.7%;组织胺:59.3 ± 1.8%)并增加了 EC(50)(卡巴胆碱:对照 3.33 ± 0.88 µM,BNP 100 ± 52.9 µM;组织胺:对照 16.7 ± 1.7 µM,BNP 90 ± 30.6 µM);BNP 在去上皮的支气管中无效。在 NPRs 中,仅在支气管组织中检测到心房 NPR(NPR1)转录本。支气管 NPR1 免疫反应性在上皮和炎症细胞中检测到,但在气道平滑肌细胞中检测到微弱或缺失。用 BNP 孵育后,支气管 NPR1 转录本增加,但致敏后则不然。甲氧基胺和奎宁消除了 BNP 诱导的松弛活性。后者与支气管中一氧化氮合酶和 NO 释放的 mRNA 增加有关,被 L-NAME 和氨基胍抑制。在体外,BNP 增加了支气管上皮细胞中乙酰胆碱的释放,而 NO 释放则不变。
上皮细胞介导了人离体支气管中 BNP 诱导的松弛活性。